NCT02322827View on ClinicalTrials.gov

Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART

CompletedOBSERVATIONAL
Enrollment

445

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Acquired Immunodeficiency SyndromeHuman Immunodeficiency Virus Type
Trial Locations (1)

33401

Triple O Research Institute PA, West Palm Beach

All Listed Sponsors
lead

Olayemi Osiyemi MD

OTHER

NCT02322827 - Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART | Biotech Hunter | Biotech Hunter